Lateral Flow Assay Market (By Product: Kits & Reagents, Lateral Flow Readers; By Application; By Technique; By Test Type; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global lateral flow assay market was surpassed at USD 12.52 billion in 2022 and is expected to hit around USD 17.00 billion by 2032, growing at a CAGR of 3.11% from 2023 to 2032.

Lateral Flow Assay Market Size 2023 to 2032

Key Pointers

  • Based on product, the kits and reagents segment held a larger revenue share in 2022.
  • The clinical testing segment held the largest share of 77.06% in 2022.
  • Sandwich assays are expected to hold the largest revenue share.
  • The lateral flow immunoassay segment held the largest revenue share in 2022.
  • The hospitals & clinics segment held the largest market share of 36.8% in 2022.
  • North America accounted for the largest revenue share of 36.4% in 2022.
Report Coverage Details
Market Size in 2022 USD 12.52 billion
Revenue Forecast by 2032 USD 17.00 billion
Growth rate from 2023 to 2032 CAGR of 3.11%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Abbott Laboratories; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc.; bioMérieux SA; Quidel Corporation; Hologic, Inc.; PerkinElmer, Inc.; Merck KGaA; BD; Siemens Healthineers; Danaher Corporation; QIAGEN N.V.

 

Lateral flow assays are used to detect the presence of a target component in the liquid sample without the need for expensive or specialized equipment. The rising prevalence of infectious diseases is anticipated to boost the growth of the lateral flow assay industry during the forecast period. For instance, according to WHO, about 10 million people worldwide suffered from tuberculosis in 2020.

Rapid detection of chronic diseases, especially infectious diseases, is necessary and should be accurate & affordable. It helps minimize the need for multiple patient visits and facilitates timely treatment & control of infectious disease outbreaks. The WHO has recommended prompt parasite-based diagnosis in all malaria-suspected patients before proper administration of treatment.

Thus, there is a growing need for rapid diagnostic test kits, facilitating prompt diagnosis and treatment. According to WHO, rapid diagnostic tests are capable of significantly improving the quality of diagnosis and management of infectious diseases, especially in areas with restricted access to advanced technologies.

The use of lateral flow devices also eliminates the need to wait for deciphering test results as well as aids in the optimization of timely treatment decisions, improves the efficacy of care provided, and significantly reduces diagnosis costs, especially in areas with resource-constrained settings and insufficient laboratory infrastructure. The rising trend of decentralized testing has been crucial in increasing the adoption of lateral flow devices globally. The role of these devices has also been observed in controlling major infectious diseases such as malaria and influenza.

According to WHO, rapid diagnostic tests are used in diagnosis by healthcare professionals distant from microscopy services; remote diagnosis by professionals in malaria-endemic countries; and outbreak investigation & survey of parasite prevalence. Thus, various benefits offered by lateral flow devices are among the key factors responsible for increasing the adoption of lateral flow devices globally.

Moreover, the rising prevalence of infectious diseases, including malaria, tuberculosis, HIV/AIDS, hepatitis, pneumonia, and influenza, is one of the major factors boosting the growth of the lateral flow assays industry. According to the World Malaria Report 2020, around 241 million malaria cases were reported in 2021, leading to over 627 thousand malaria-related deaths globally.

As per the data from the IDF Diabetes Atlas, there were about 537 million adults living with diabetes in 2021, and this number is anticipated to increase to 643 million by 2030. The disease is estimated to have caused 6.7 million deaths in 2021. Thus, with the rising incidence of chronic diseases, the demand for lateral flow assays is likely to increase in the coming years.

Lateral Flow Assay Market Segmentations:

By Product 

  • Kits & Reagents
  • Lateral Flow Readers
    • Lateral Flow Readers
    • Benchtop Readers
    • Digital Readers

By Application 

  • Clinical Testing
    • Infectious Disease Testing
      • COVID-19
      • Mosquito Borne Disease Testing
      • Influenza Testing
      • Sexually Transmitted Infection Testing
        • STI Testing
        • HIV Testing
        • HPV Testing
        • Chlamydia Testing
        • Gonorrhea Testing
        • Syphilis Testing
        • Other STI Testing
      • Hepatitis
      • Tuberculosis
      • Other Infectious Diseases
    • Cardiac Marker Testing
      • Troponin I and T Testing
      • CK-MB Testing
      • BNP and NT-Probnp Testing
      • Myoglobin Testing
      • D-Dimer Testing
      • Other Cardiac Marker Tests
    • Pregnancy & Fertility Testing
      • Pregnancy Testing
      • Fertility Testing
    • Cholesterol Testing/Lipid Profile
    • Drugs of Abuse Testing
    • Other Clinical Tests
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

By Technique 

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Test Type

  • Lateral Flow Immunoassay
  • Nucleic Acid Lateral Flow Assay

By End-user

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical & Biotechnology Companies
  • Others

Frequently Asked Questions

The global lateral flow assay market size was reached at USD 12.52 billion in 2022 and it is projected to hit around USD 17.00 billion by 2032.

The global lateral flow assay market is growing at a compound annual growth rate (CAGR) of 3.11% from 2023 to 2032.

The North America region has accounted for the largest lateral flow assay market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Lateral Flow Assay Market 

5.1. COVID-19 Landscape: Lateral Flow Assay Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Lateral Flow Assay Market, By Product

8.1. Lateral Flow Assay Market, by Product, 2023-2032

8.1.1. Kits & Reagents

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Lateral Flow Readers

8.1.2.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Lateral Flow Assay Market, By Application

9.1. Lateral Flow Assay Market, by Application, 2023-2032

9.1.1. Clinical Testing

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Veterinary Diagnostics

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Food Safety & Environment Testing

9.1.3.1. Market Revenue and Forecast (2019-2032)

9.1.4. Drug Development & Quality Testing

9.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Lateral Flow Assay Market, By Technique 

10.1. Lateral Flow Assay Market, by Technique, 2023-2032

10.1.1. Sandwich Assays

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Competitive Assays

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. Multiplex Detection Assays

10.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Lateral Flow Assay Market, By Test Type

11.1. Lateral Flow Assay Market, by Test Type, 2023-2032

11.1.1. Lateral Flow Immunoassay

11.1.1.1. Market Revenue and Forecast (2019-2032)

11.1.2. Nucleic Acid Lateral Flow Assay

11.1.2.1. Market Revenue and Forecast (2019-2032)

Chapter 12. Global Lateral Flow Assay Market, By End-user

12.1. Lateral Flow Assay Market, by End-user, 2023-2032

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Forecast (2019-2032)

12.1.2. Diagnostic Laboratories

12.1.2.1. Market Revenue and Forecast (2019-2032)

12.1.3. Home Care

12.1.3.1. Market Revenue and Forecast (2019-2032)

12.1.4. Pharmaceutical & Biotechnology Companies

12.1.4.1. Market Revenue and Forecast (2019-2032)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2019-2032)

Chapter 13. Global Lateral Flow Assay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2019-2032)

13.1.2. Market Revenue and Forecast, by Application (2019-2032)

13.1.3. Market Revenue and Forecast, by Technique (2019-2032)

13.1.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.1.5. Market Revenue and Forecast, by End-user (2019-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2019-2032)

13.1.6.2. Market Revenue and Forecast, by Application (2019-2032)

13.1.6.3. Market Revenue and Forecast, by Technique (2019-2032)

13.1.6.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.1.7. Market Revenue and Forecast, by End-user (2019-2032) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2019-2032)

13.1.8.2. Market Revenue and Forecast, by Application (2019-2032)

13.1.8.3. Market Revenue and Forecast, by Technique (2019-2032)

13.1.8.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.1.8.5. Market Revenue and Forecast, by End-user (2019-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2019-2032)

13.2.2. Market Revenue and Forecast, by Application (2019-2032)

13.2.3. Market Revenue and Forecast, by Technique (2019-2032)

13.2.4. Market Revenue and Forecast, by Test Type (2019-2032) 

13.2.5. Market Revenue and Forecast, by End-user (2019-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2019-2032)

13.2.6.2. Market Revenue and Forecast, by Application (2019-2032)

13.2.6.3. Market Revenue and Forecast, by Technique (2019-2032)

13.2.7. Market Revenue and Forecast, by Test Type (2019-2032) 

13.2.8. Market Revenue and Forecast, by End-user (2019-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2019-2032)

13.2.9.2. Market Revenue and Forecast, by Application (2019-2032)

13.2.9.3. Market Revenue and Forecast, by Technique (2019-2032)

13.2.10. Market Revenue and Forecast, by Test Type (2019-2032)

13.2.11. Market Revenue and Forecast, by End-user (2019-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2019-2032)

13.2.12.2. Market Revenue and Forecast, by Application (2019-2032)

13.2.12.3. Market Revenue and Forecast, by Technique (2019-2032)

13.2.12.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.2.13. Market Revenue and Forecast, by End-user (2019-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2019-2032)

13.2.14.2. Market Revenue and Forecast, by Application (2019-2032)

13.2.14.3. Market Revenue and Forecast, by Technique (2019-2032)

13.2.14.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.2.15. Market Revenue and Forecast, by End-user (2019-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2019-2032)

13.3.2. Market Revenue and Forecast, by Application (2019-2032)

13.3.3. Market Revenue and Forecast, by Technique (2019-2032)

13.3.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.3.5. Market Revenue and Forecast, by End-user (2019-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2019-2032)

13.3.6.2. Market Revenue and Forecast, by Application (2019-2032)

13.3.6.3. Market Revenue and Forecast, by Technique (2019-2032)

13.3.6.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.3.7. Market Revenue and Forecast, by End-user (2019-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2019-2032)

13.3.8.2. Market Revenue and Forecast, by Application (2019-2032)

13.3.8.3. Market Revenue and Forecast, by Technique (2019-2032)

13.3.8.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.3.9. Market Revenue and Forecast, by End-user (2019-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2019-2032)

13.3.10.2. Market Revenue and Forecast, by Application (2019-2032)

13.3.10.3. Market Revenue and Forecast, by Technique (2019-2032)

13.3.10.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.3.10.5. Market Revenue and Forecast, by End-user (2019-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2019-2032)

13.3.11.2. Market Revenue and Forecast, by Application (2019-2032)

13.3.11.3. Market Revenue and Forecast, by Technique (2019-2032)

13.3.11.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.3.11.5. Market Revenue and Forecast, by End-user (2019-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2019-2032)

13.4.2. Market Revenue and Forecast, by Application (2019-2032)

13.4.3. Market Revenue and Forecast, by Technique (2019-2032)

13.4.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.4.5. Market Revenue and Forecast, by End-user (2019-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2019-2032)

13.4.6.2. Market Revenue and Forecast, by Application (2019-2032)

13.4.6.3. Market Revenue and Forecast, by Technique (2019-2032)

13.4.6.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.4.7. Market Revenue and Forecast, by End-user (2019-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2019-2032)

13.4.8.2. Market Revenue and Forecast, by Application (2019-2032)

13.4.8.3. Market Revenue and Forecast, by Technique (2019-2032)

13.4.8.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.4.9. Market Revenue and Forecast, by End-user (2019-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2019-2032)

13.4.10.2. Market Revenue and Forecast, by Application (2019-2032)

13.4.10.3. Market Revenue and Forecast, by Technique (2019-2032)

13.4.10.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.4.10.5. Market Revenue and Forecast, by End-user (2019-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2019-2032)

13.4.11.2. Market Revenue and Forecast, by Application (2019-2032)

13.4.11.3. Market Revenue and Forecast, by Technique (2019-2032)

13.4.11.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.4.11.5. Market Revenue and Forecast, by End-user (2019-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2019-2032)

13.5.2. Market Revenue and Forecast, by Application (2019-2032)

13.5.3. Market Revenue and Forecast, by Technique (2019-2032)

13.5.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.5.5. Market Revenue and Forecast, by End-user (2019-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2019-2032)

13.5.6.2. Market Revenue and Forecast, by Application (2019-2032)

13.5.6.3. Market Revenue and Forecast, by Technique (2019-2032)

13.5.6.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.5.7. Market Revenue and Forecast, by End-user (2019-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2019-2032)

13.5.8.2. Market Revenue and Forecast, by Application (2019-2032)

13.5.8.3. Market Revenue and Forecast, by Technique (2019-2032)

13.5.8.4. Market Revenue and Forecast, by Test Type (2019-2032)

13.5.8.5. Market Revenue and Forecast, by End-user (2019-2032)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Thermo Fisher Scientific, Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. F. Hoffmann-La Roche AG

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bio-Rad Laboratories, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. bioMérieux SA

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Quidel Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Hologic, Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. PerkinElmer, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Merck KGaA

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. BD

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers